(Q35159097)

6 August 2017

1 reference

title

Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis (English)

1 reference

6 August 2017

3

Jorge E Osorio

1 reference

6 August 2017

Deborah Fuller

2

1 reference

ORCID Public Data File 2021

author name string

Hansi J Dean

series ordinal

1

1 reference

PubMed ID

12818623

6 August 2017

language of work or name

1 reference

1 October 2003

1 reference

Comparative Immunology, Microbiology & Infectious Diseases

6 August 2017

1 reference

6 August 2017

26

1 reference

6 August 2017

5-6

1 reference

6 August 2017

373-388

1 reference

DNA-based immunization by in vivo transfection of dendritic cells

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Oral mucosal Langerhans' cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Capture and processing of exogenous antigens for presentation on MHC molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

1 reference

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

CTL-defined cancer vaccines: perspectives for active immunotherapeutic interventions in minimal residual disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Protection from pathogenic SIV challenge using multigenic DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Clinical experience with hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

Adjuvantation of epidermal powder immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900021-3

7 January 2021

10.1016/S0147-9571(03)00021-3

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12818623